Laboratory Management & Diagnostics will go in depth to look at how the laboratory can improve on results using new technology, while also saving costs and providing stronger outcomes for the patients.    With the healthcare system moving towards preventative and value-based medicine, the medical laboratory will have a significant role to play in this improvement.   

This conference will bring together experts from around KSA to ensure necessary discussions that will lead to further research and development in key diagnostic areas. As well as discuss the challenges faced, with stimulating conversations on how to improve and face these difficulties.  

Key topics:

• Transformation of labs
• COVID-19 current issues and challenges
• Bio-safety and security in medical laboratories
• Molecular diagnosis of COVID-19: Current situation and trend
  

Benefits of attending:

• Review the emerging biomarkers for prostate cancer 
• Discuss the challenges of developing a laboratory test 
• Evaluate benefits associated with the implementation of digital pathology
• Recognise both emerging and reemerging multi-drug resistant pathogens
  

Speakers:

Conference Chair

Dr Kamel Mohammed Aldosari, General Director for Laboratories & Blood Banks in Riyadh Region, Associate Professor of Transfusion Medicine & Hematopathology, Ministry of Health, Riyadh, KSA

Conference co-chair:

Dr Abdulwahab Zaid Binjomah, Assistant Director of Regional Laboratory for Quality, Safety & Infection Control, Head of Microbiology Department, Riyadh Reference Laboratory, Riyadh, KSA

Speakers:

• Dr Ali Albarrak, Consultant Internal Medicine & Infectious Diseases , Prince Sultan Military Medical City (PSMMC), Medical Services Directorate, Ministry of Defense, Riyadh, KSA
• Dr Bandar Al Osaimi, Assistant Professor, Viral-oncology and Cancer Sciences, Research Center, King Fahad Medical City, Riyadh, KSA
• Dr Fatima Al-Hamlan, Chair, Scientist and Assistant Professor, Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, KSA
• Prof Julian Hiscox, Chair in Infection and Global Health Infection Biology, University of Liverpool, Liverpool, UK
• Dr Maysoon Mutabagani, Assistant Head, Clinical Laboratory, King Faisal Specialist Hospital & Research Centre, Riyadh, KSA
• Mazen Singer. Head of Infrastructure and Real Estate Solutions. KPMG, Riyadh, KSA
• Prof Mike Barer, Professor of Clinical Microbiology and Honorary Consultant Microbiologist, University of Leicester, Leicester, UK
• Dr Mohammed Al Mohammadi, Chairman, Pathology and Laboratory Medicine, Consultant Hematophatology/Transfusion Medicine/Stem, King Saud bin Abdulaziz University, Jeddah, KSA

• Naif Al Harbi, Director of Vaccine Development Unit, Head of Research Quality Management, King Abdullah International Medical Research Center (KAIMRC), Riyadh, KSA
• Dr Saud Alshehri, Microbiologist, Biological Disaster Management, Armed Forces Medical Services, Riyadh, KSA
• Prof Tamir Abdelrahman, Chairman of Microbiology, National Health Laboratory, Luxemobourg City, Luxembourg
• Dr Walid Alsalim, Neglected Tropical Diseases Consultant, Consultant to Deputy Health Minister, Ministry of Health, Riyadh, KSA
• Dr Yasser Assiri, Program Manager, Transformation and Private Sector Participation in Medical Imaging and Laboratory, VRO-PSP, Ministry of Health, Riyadh, KSA
• Prof Zaki Monawer Eisa, Director, Weqaya – Saudi Center for Disease Prevention and Control, Jazan, KSA